These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5683068)

  • 1. [Extraction of encephalitogenic substances from the tissues of the central nervous system and testing of their activity].
    Boroş I; Bordeianu A
    Stud Cercet Fiziol; 1968; 13(3):235-45. PubMed ID: 5683068
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental allergic encephalomyelitis: immunological properties of encephalitogenic polypeptides and proteins.
    Lamoureux G; Carnegie PR; McPherson TA; Johnston D
    Clin Exp Immunol; 1967 Sep; 2(5):601-9. PubMed ID: 4965043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of organ-specific antigens of the central nervous system.
    Alvord EC; Hruby S; Hughes K; Shaw CM; Kies MW
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:276-92. PubMed ID: 5373030
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic unresponsiveness, immunity and enhancement in experimental allergic encephalomyelitis.
    Salvin SB; Liauw HL
    J Immunol; 1968 Jul; 101(1):33-42. PubMed ID: 4173936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of the protective effect of hyperimmune anti-nervous system serum against experimental allergic encephalomyelitis].
    Moulias R; Peetoom F
    Pathol Biol; 1968 Oct; 16(19):859-63. PubMed ID: 4302103
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiplicity of encephalitogenic myelin basic proteins. II. Antigenic determinants related to species of origin and molecular size.
    Alvord EC; Hruby S; Shaw CM; Kies MW
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:203-17. PubMed ID: 4984656
    [No Abstract]   [Full Text] [Related]  

  • 7. An in vitro assay for encephalitogenic components of central nervous tissue.
    Brockman JA; Stiffey AV; Tesar WC
    J Immunol; 1968 Jun; 100(6):1230-6. PubMed ID: 5696285
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation of encephalitogenic fractions from human brain.
    Vepreková A; Pekárek J; Doutlík S; Pavlík V; Jedlicka P
    Z Immunitatsforsch Exp Klin Immunol; 1972; 142(5):448-54. PubMed ID: 4258923
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of non-encephalitogenic fraction isolated from human brain for the detection of EAE development in guinea-pigs.
    Pekárek J; Doutlík S; Vepreková A; Jedlicka P
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Aug; 140(2):177-83. PubMed ID: 4248066
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of experimental "allergic" encephalomyelitis in guinea pigs by encephalitogenic proteins extracted from homologous brain.
    SHAW CM; FAHLBERG WJ; KIES MW; ALVORD EC
    J Exp Med; 1960 Feb; 111(2):171-80. PubMed ID: 13831267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental allergic encephalitogenic substance].
    Yonezawa T; Ishihara Y; Nakatani Y; Iizuka R; Mori T
    Shinkei Kenkyu No Shimpo; 1969 Jun; 13(2):346-54. PubMed ID: 5390678
    [No Abstract]   [Full Text] [Related]  

  • 12. Central nervous system and blood lymphocytes in experimental allergic encephalomyelitis.
    Lublin FD; Tippett DL; Maurer PH
    J Clin Lab Immunol; 1983 Mar; 10(3):139-42. PubMed ID: 6842578
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility and resistance to experimental autoimmune encephalomyelitis and neuritis in the guinea pig correlate with the induction of procoagulant and anticoagulant activities.
    Geczy CL; Roberts IM; Meyer P; Bernard CC
    J Immunol; 1984 Dec; 133(6):3026-36. PubMed ID: 6208270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic protein from central nervous system myelin.
    Hashim GA
    Prog Clin Biol Res; 1980; 49():79-122. PubMed ID: 6163164
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antigen of experimental demyelinating diseases].
    Kiyota K
    Nihon Rinsho; 1970 Sep; 28(9):2200-5. PubMed ID: 4918160
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution of 14C-labelled encephalitogenic factor after intracutaneous inoculation.
    Caspary EA; Field EJ
    J Neurol Sci; 1970 Sep; 11(3):257-64. PubMed ID: 5505687
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure of an encephalitogenic protein.
    Kibler RF; Shapira R
    Trans Am Neurol Assoc; 1969; 94():38-41. PubMed ID: 5374488
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
    Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the encephalitogenic effect of typhoid bacteria in guinea pigs].
    Kanchurin AKh; Volynskiĭ MIa
    Biull Eksp Biol Med; 1968 Jan; 65(1):87-9. PubMed ID: 5652294
    [No Abstract]   [Full Text] [Related]  

  • 20. Localization of antigenic determinants on bovine encephalitogenic protein: disease-inducing activity of fragment 44-68 in rabbits.
    Bergstrand H
    Neurobiology; 1973; 3(2):124-9. PubMed ID: 16100960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.